Related Experiment Video
Updated: Jun 19, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Should children with inherited metabolic disorders receive varicella vaccination?
M Varghese1, M Cafferkey, M O'Regan
1National Centre for Inherited Metabolic Disorders, Children's University Hospital, Dublin, Ireland.
Insights
Children with disorders of intermediary metabolism (IEM) face increased risks of severe varicella (chickenpox) complications. Varicella vaccination may be beneficial for this vulnerable pediatric population.
Area of Science:
- Pediatric Infectious Diseases
- Metabolic Disorders
- Immunization
Background:
- Disorders of intermediary metabolism (IEM) represent a group of rare genetic conditions affecting metabolic pathways.
- Varicella (chickenpox) is a common childhood viral illness, typically mild but can cause severe complications in immunocompromised or chronically ill individuals.
Purpose of the Study:
- To determine the incidence and severity of varicella infections and associated complications in children diagnosed with IEMs.
- To evaluate the potential benefit of varicella vaccination in this specific pediatric cohort.
Main Methods:
- Retrospective review of medical records for children aged 1-16 years attending a national metabolic referral center.
- Data collection included history of varicella infection, vaccination status, and occurrence of complications.
Main Results:
- Out of 122 children with IEMs, 64 (53%) had a history of varicella infection, and 5 (4%) were vaccinated.
- Five children with a history of varicella infection required hospitalization for complications, including lactic acidosis and metabolic decompensation.
- Forty-three percent of patients lacked a clear history of clinical varicella infection.
Conclusions:
- Varicella infection poses a significant risk of precipitating metabolic decompensation in children with IEMs.
- Consideration of varicella vaccination for children with IEMs is recommended, with careful monitoring of safety and efficacy.
Abstract:
The aim was to determine the rate of varicella infection and complications in children with disorders of intermediary metabolism (IEM) between the ages of 1 and 16 years attending our national metabolic referral centre. Of 126 children identified, a response was received from 122. A history of previous varicella infection was identified in 64 cases (53%) and of varicella vaccination in 5 (4%). Fifty-three (43%) patients apparently did not have a history of clinical varicella infection. Of the 64 children with a history of varicella infection, five required hospitalisation for complications, including life-threatening lactic acidosis in one patient with mitochondrial disease and metabolic decompensation in four patients. In conclusion, varicella infection may cause an increased risk of metabolic decompensation in patients with IEMs. We propose that a trial of varicella vaccination be considered for this cohort of patients with monitoring of its safety and efficacy.
Related Concept Videos
Chickenpox
Inborn Errors of Metabolism
Respiratory Syncytial Virus Disease
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Vaccinations
Cytomegalovirus Disease
